Abstract | BACKGROUND: METHODS: RESULTS: Seven of the 11 eyes in group 1 developed more severe retinoschisis, the mean maximal retinal thickness increased from (380.28 ± 90.13) to (467.00 ± 70.20) µm (P < 0.05). The retinoschisis of all 6 eyes of the control group did not aggravate. Compared with the control group, the aggravation ratio of retinoschisis increased significantly (P < 0.05). No new onset of retinoschisis took place in group 2 and group 3. CONCLUSION:
|
Authors | Jianfeng Huang, Tong Chen, Yingyi Lu, Li Long, Hong Dai |
Journal | Chinese medical journal
(Chin Med J (Engl))
Vol. 127
Issue 11
Pg. 2053-7
( 2014)
ISSN: 2542-5641 [Electronic] China |
PMID | 24890151
(Publication Type: Journal Article)
|
Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal, Humanized
- Ranibizumab
|
Topics |
- Adult
- Angiogenesis Inhibitors
(administration & dosage, therapeutic use)
- Antibodies, Monoclonal, Humanized
(administration & dosage, therapeutic use)
- Choroidal Neovascularization
(drug therapy)
- Female
- Humans
- Intravitreal Injections
- Male
- Middle Aged
- Myopia, Degenerative
(drug therapy)
- Ranibizumab
- Retinoschisis
(drug therapy)
- Retrospective Studies
- Treatment Outcome
|